Aldeyra Therapeutics, Inc. (ALDX) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 16, 2026.
- Filings shown
- 11
- Open-market buys
- 4
- Open-market sells
- 0
- Buys, 10b5-1 box not checked
- 4 of 4
Counts cover the 11 most recent Form 4 filings Tradune holds for ALDX (filed Jun 5 – Nov 16, 2026); the score below covers only the trailing 90 days (3 buys, 0 sells). SEC EDGAR Form 4 filings for ALDX last checked Nov 21, 2026, 09:00 UTC; the latest ALDX filing Tradune holds was filed Nov 16, 2026. This is not guaranteed to be the complete record — see ALDX's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 3 filings Tradune holds for ALDX filed Nov 13 – Nov 16, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Richard DouglasDirector | 1 | 0 | 200,000 | — | +$128,900 |
| Michael AlfieriPrincipal Financial Officer | 1 | 0 | 10,000 | — | +$6,500 |
| Darlene M. Deptula-HicksDirector | 1 | 0 | 7,500 | — | +$4,875 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
100/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
Weekly signal history
ALDX appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.
- Week of Nov 17, 2026 3 insiders buying · $140,275 net
An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ALDX
Insiders reported 4 open-market purchases of ALDX between Jun 5, 2026 and Nov 16, 2026, across 4 distinct buyers. The most recent purchase was reported by Darlene M. Deptula-Hicks (Director) on Nov 12, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 7,500 | $0.65 | 7,500 | — | Nov 12, 2026 |
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 10,000 | $0.65 | 17,500 | +133% | Nov 11, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 200,000 | $0.64 | 395,000 | +103% | Nov 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 70,000 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 3,318 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 70,000 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 19,909 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 2,323 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 70,000 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 6,636 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 4,977 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 70,000 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 2,323 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 70,000 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 3,318 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 70,000 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 5,309 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 4,977 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 84,557 | — | — | — | Jun 9, 2026 |
| Grant / award Stock Option (Right to Buy) | 9,756 | — | — | — | Jun 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 250,000 | $1.67 | 1,721,298 | +17% | Jun 3, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ALDX's (Nov 16, 2026).
Frequently asked about ALDX insider activity
How many insiders bought ALDX stock in these Form 4 filings?
4 distinct insiders at Aldeyra Therapeutics, Inc. reported 4 open-market purchases (Form 4 code P) of ALDX shares between Jun 5, 2026 and Nov 16, 2026, the most recent filed by Darlene M. Deptula-Hicks (Director) on Nov 12, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for ALDX?
The most recent Form 4 on this page was filed by Darlene M. Deptula-Hicks (Director) on Nov 16, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ALDX insider purchase shown?
The largest open-market purchase among the filings shown was 250,000 ALDX shares at $1.67 (about $418,450) by Todd C. Brady (President and CEO) on Jun 3, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent ALDX insider purchases have the Form 4 10b5-1 box checked?
No. All 4 ALDX open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Darlene M. Deptula-Hicks (Director) on Nov 12, 2026, 7,500 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ALDX — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.